Body Organ Biomedical Corporation (BOBC) is a company dedicated in the innovative and high value added class III medical device, tissue engineering and life science products and technology development. The core value of BOBC is to set up international sales and marketing platform, strong brand awareness and technology holder. BOBC has filed six patents worldwide and the products commercialization is undergoing. BOBC is working on the both ends of smiling curve and has gained preliminary recognition from ophthalmic scenario. BOBC has subsidiaries in the Netherlands and the USA.
BOBC employs AEON ASTRON EUROPE B.V. (AAE, a Dutch subsidiary company) for internationals sales and marketing, regulatory certificates holder. BOBC's business covers ophthalmology, orthopedic, aesthetic and reconstructive plastic surgery and dentistry. One product, ologen collagen matrix for eye tissue repair is already marketed in more than 30 countries and the others products more will be launched in the coming years. The ologen product is now selling in USA, Europe, the Middle East, India, Malaysia, Hong Kong and South America.
The major effort we do now is developing bio cornea, bio lens, aesthetic product, orthopedic products and dental plug+GBR product. These products launch is estimated in year 2012 and afterward. For more information, please check www.oculusgen.com or www.aeonastron.com.
BOBC is continuing its research and development and have filed more than 8 patents to more than 30 destinations.
As to biocornea, AAE is working with the world leading ophthalmologists from the Netherlands, UK, Germany, Belgium and Denmark. The biocornea may restore the vision for the corneal blindness that will be the substitute of human cornea. We are also working for bio lens that is not only as a contact lens but for corneal repair and drug carrier.
We are in the field of regenerative medicine with global operation. We aim to become one of the leading tissue engineering companies in the world.
- Aongen/ologen collagen matrix for tissue repair and augmentation, aongen dermal filler, ologen plano bandage lens, aongen orthopedic, Aeon Col-Hap injectable dermal filler, Col-Hap bone filler, biodegradable bone plate. Research on BIOCORNEA has gained great opportunity of commercialization.
BOBC has filed more than 30 products and one technology patents to USPTO, PCT and related authorities and 10 has granted. The strategy is use Taiwan as research and production base. The Netherlands is the marketing and regulatory units. US operation will commence soon.
Three brands: oculusgen, ologen and aongen.
Potential and qualified managers get the chance for re-allocation.